HighPoint Advisor Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.87M Buy
26,827
+2,716
+11% +$190K 0.1% 164
2025
Q1
$1.73M Buy
24,111
+1,931
+9% +$138K 0.1% 160
2024
Q4
$1.61M Sell
22,180
-188
-0.8% -$13.7K 0.09% 181
2024
Q3
$1.6M Sell
22,368
-1,343
-6% -$95.9K 0.09% 170
2024
Q2
$1.85M Sell
23,711
-4,163
-15% -$324K 0.11% 148
2024
Q1
$2.16M Buy
27,874
+7,338
+36% +$568K 0.15% 117
2023
Q4
$1.35M Buy
+20,536
New +$1.35M 0.1% 173
2022
Q2
$967K Buy
+14,545
New +$967K 0.11% 157
2021
Q3
$1.05M Buy
17,549
+491
+3% +$29.5K 0.1% 156
2021
Q2
$1.02M Buy
17,058
+2,690
+19% +$161K 0.1% 163
2021
Q1
$718K Buy
14,368
+264
+2% +$13.2K 0.08% 195
2020
Q4
$711K Buy
14,104
+4,025
+40% +$203K 0.09% 190
2020
Q3
$556K Buy
10,079
+5,169
+105% +$285K 0.1% 171
2020
Q2
$262K Sell
4,910
-30
-0.6% -$1.6K 0.06% 264
2020
Q1
$252K Sell
4,940
-175
-3% -$8.93K 0.06% 246
2019
Q4
$259K Sell
5,115
-453
-8% -$22.9K 0.05% 287
2019
Q3
$263K Buy
5,568
+96
+2% +$4.53K 0.06% 268
2019
Q2
$220K Buy
5,472
+53
+1% +$2.13K 0.05% 295
2019
Q1
$205K Sell
5,419
-201
-4% -$7.6K 0.05% 307
2018
Q4
$227K Sell
5,620
-1,600
-22% -$64.6K 0.06% 274
2018
Q3
$285K Sell
7,220
-754
-9% -$29.8K 0.08% 236
2018
Q2
$303K Sell
7,974
-1,291
-14% -$49.1K 0.08% 228
2018
Q1
$337K Sell
9,265
-1,285
-12% -$46.7K 0.09% 216
2017
Q4
$359K Buy
10,550
+229
+2% +$7.79K 0.1% 198
2017
Q3
$352K Buy
10,321
+956
+10% +$32.6K 0.11% 194
2017
Q2
$283K Hold
9,365
0.09% 215
2017
Q1
$283K Buy
9,365
+1,046
+13% +$31.6K 0.09% 215
2016
Q4
$244K Sell
8,319
-2,659
-24% -$78K 0.08% 242
2016
Q3
$300K Buy
10,978
+1,516
+16% +$41.4K 0.11% 213
2016
Q2
$323K Buy
9,462
+3,597
+61% +$123K 0.11% 191
2016
Q1
$177K Sell
5,865
-780
-12% -$23.5K 0.11% 191
2015
Q4
$209K Buy
+6,645
New +$209K 0.14% 173